New research from MCB Associate Professor David Savage and MCB & Chemistry Professor Jennifer Doudna shows that an enzyme called ProCas9 can be used to target specific cells during CRISPR gene editing.
“This is an extra layer of security you could put on the molecule to ensure accurate cutting,” said Savage.